Health Linkages, Inc.

Health Linkages, Inc. provides advanced data provenance solutions for secure and auditable sharing of health-related data across healthcare organizations, utilizing technologies such as blockchain and artificial intelligence. Founded in 2016 and headquartered in Mountain View, US, Health Linkages, Inc. specializes in solutions for the secure sharing of healthcare data.

The company was founded by Robert Barkovich, who has a history in health technology and previously launched other ventures. In March 2017, Health Linkages raised seed funding from IndieBio and SOSV, allowing them to expand their offerings and market presence. Health Linkages specializes in data provenance solutions that enable trusted, secure, and auditable sharing of health-related data across various platforms and organizations. Their core offerings focus on maintaining oversight and control of shared data, ensuring compliance with regulations such as GDPR and HIPAA, and providing a complete event history for every data point through advanced technology frameworks like blockchain and artificial intelligence.

End users include healthcare providers, research institutions, and organizations seeking to enhance data governance and integrity across their operations, primarily in North America and Europe. Health Linkages generates revenue through structured partnerships and subscription models, offering clients access to proprietary data management solutions. Clients engage in subscription agreements for ongoing access to core technologies for secure data sharing and governance. Their pricing structure is tiered, catering to various organizational needs based on the number of data points managed or the level of service required, with key products facilitating seamless data exchange while ensuring compliance and data integrity for healthcare stakeholders.

Health Linkages plans to enhance its product offerings by designing new data management solutions aimed at improving healthcare data governance. The company targets expansion into additional European markets by 2025, leveraging recent funding raised in March 2017, which will be utilized to support product development and market entry initiatives.